{"database": "openregs", "table": "documents", "rows": [["FDA-2023-N-2177-7045", "FDA", "FDA-2023-N-2177", "Reference 195 - FDA, 510(k) Substantial Equivalence Determination Decision Summary, BD Respiratory Viral Panel (BD RVP) for BD MAX System; BD Respiratory Viral Panel-SCV2 (BD RVP-SCV2) for BD MAX System, K230956, Decision Date July 31, 2023", "Supporting & Related Material", "Background Material", "2024-05-06T04:00:00Z", 2024, 5, null, null, "2024-05-06T16:36:46Z", null, 0, 0, "090000648652c9c4"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-N-2177-7045"], "units": {}, "query_ms": 0.38721296004951, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}